Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | -0.79% | -5.62% | -32.98% |
May. 15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
May. 14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.5M | Capitalization | 83.67M |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | -120M | EV / Sales 2024 * | - |
Net cash position 2024 * | 37.38M | Net cash position 2025 * | 266M | EV / Sales 2025 * | -122 x |
P/E ratio 2024 * |
-0.91
x | P/E ratio 2025 * |
-0.98
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.77% |
Latest transcript on IO Biotech, Inc.
1 day | -3.79% | ||
1 week | -7.97% | ||
Current month | -13.01% | ||
1 month | -10.56% | ||
3 months | -20.13% | ||
6 months | -6.62% | ||
Current year | -32.45% |
Managers | Title | Age | Since |
---|---|---|---|
Mai-Britt Zocca
FOU | Founder | 56 | 14-11-30 |
Amy Sullivan
DFI | Director of Finance/CFO | 54 | 22-10-14 |
Eric Faulkner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Smith
BRD | Director/Board Member | 64 | 22-02-28 |
K. Hirth
CHM | Chairman | 72 | 16-08-31 |
Kathleen Glaub
BRD | Director/Board Member | 70 | 18-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 1.26 | -0.79% | 121 820 |
24-05-24 | 1.27 | -3.79% | 68,394 |
24-05-23 | 1.32 | -0.75% | 136,046 |
24-05-22 | 1.33 | -0.37% | 134,868 |
24-05-21 | 1.335 | -3.26% | 46,450 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.45% | 83.67M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.81% | 40.47B | |
-10.87% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- IOBT Stock